Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions.
Amalia S MagaretShevin T JacobM Elizabeth HalloranKatherine A GuthrieCraig A MagaretChristine JohnstonNoah R SimonAnna WaldPublished in: Annals of internal medicine (2020)